Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001420720-26-000020
Filing Date
2026-08-28
Accepted
2026-08-28 08:32:57
Documents
131
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-K ibio-20260731x10k.htm   iXBRL 10-K 2877275
2 EX-4.2 ibio-20260731xex4d2.htm EX-4.2 19172
3 EX-10.39 ibio-20260731xex10d39.htm EX-10.39 290272
4 EX-23.1 ibio-20260731xex23d1.htm EX-23.1 6569
5 EX-31.1 ibio-20260731xex31d1.htm EX-31.1 21150
6 EX-31.2 ibio-20260731xex31d2.htm EX-31.2 20968
7 EX-32.1 ibio-20260731xex32d1.htm EX-32.1 8876
8 EX-32.2 ibio-20260731xex32d2.htm EX-32.2 8083
9 GRAPHIC ibio-20260731x10k001.jpg GRAPHIC 63805
10 GRAPHIC ibio-20260731x10k002.jpg GRAPHIC 62110
11 GRAPHIC ibio-20260731x10k003.jpg GRAPHIC 91618
12 GRAPHIC ibio-20260731x10k004.jpg GRAPHIC 26671
13 GRAPHIC ibio-20260731x10k005.jpg GRAPHIC 63687
14 GRAPHIC ibio-20260731x10k006.jpg GRAPHIC 93809
15 GRAPHIC ibio-20260731x10k007.jpg GRAPHIC 75224
16 GRAPHIC ibio-20260731x10k008.jpg GRAPHIC 48540
17 GRAPHIC ibio-20260731x10k009.jpg GRAPHIC 68270
18 GRAPHIC ibio-20260731x10k010.jpg GRAPHIC 61301
  Complete submission text file 0001420720-26-000020.txt   15769723

Data Files

Seq Description Document Type Size
19 EX-101.SCH ibio-20260731.xsd EX-101.SCH 104831
20 EX-101.CAL ibio-20260731_cal.xml EX-101.CAL 87029
21 EX-101.DEF ibio-20260731_def.xml EX-101.DEF 489264
22 EX-101.LAB ibio-20260731_lab.xml EX-101.LAB 783657
23 EX-101.PRE ibio-20260731_pre.xml EX-101.PRE 736916
135 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20260731x10k_htm.xml XML 2224062
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-35023 | Film No.: 261333073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)